SUMF1


Summary: This gene encodes an enzyme that catalyzes the hydrolysis of sulfate esters by oxidizing a cysteine residue in the substrate sulfatase to an active site 3-oxoalanine residue, which is also known as C-alpha-formylglycine. Mutations in this gene cause multiple sulfatase deficiency, a lysosomal storage disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009].

Loading, please wait...
Name
OMIM ID
Ensembl ID
HGNC ID
PHARMGKB ID
Map Location

Gene Categories:

DRUGGABLE GENOME

GO terms in SUMF1


Loading, please wait...
Term Type
Evidence Type
GO Term ID
GO Des.
MF TAS GO:0016491 oxidoreductase activity
MF IEA GO:0042803 protein homodimerization activity
MF IDA GO:0120147 Formylglycine-generating oxidase activity
MF IDA GO:1903135 cupric ion binding
CC IBA GO:0005783 endoplasmic reticulum
CC IDA GO:0005783 endoplasmic reticulum
Showing 1 to 6 of 11 rows rows per page

Gene expression in normal tissue: SUMF1

Gene-model tissue-cancer distribution: Bubble Plot

undefinetissue: undefine cancer: undefined model num: 0undefinedtissue: undefined cancer: PANCAN model num: 2

Gene-drug pathway distribution

ERK MAPK signaling1

Pathways in SUMF1


Loading, please wait...
Database
Pathway ID
Pathway Des.
reactome R-HSA-1430728 Metabolism
reactome R-HSA-163841 Gamma carboxylation, hypusine formation and arylsulfatase activation
reactome R-HSA-1660662 Glycosphingolipid metabolism
reactome R-HSA-1663150 The activation of arylsulfatases
reactome R-HSA-392499 Metabolism of proteins
reactome R-HSA-428157 Sphingolipid metabolism
Showing 1 to 6 of 9 rows

Gene-Drug: Aster Plot


Loading, please wait...
Drug ID
Drug Name
Model Num.
iGMDRD353 PD0325901 2
Showing 1 to 1 of 1 rows

Gene in drug-gene network: Network Plot

Gene-drug targets distribution

Gene Structure: PDB

Models in SUMF1

Loading, please wait...
Model
Level
Reference ID
Tissue
Cancer
Drug
Clinical Response
Source
No matching records found

​​​​